Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03682796 |
Title | Study of TRPH-222 in Patients With Relapsed and/or Refractory B-Cell Lymphoma |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Triphase Research and Development III Corp. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | CAN |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Banner MD Anderson | Gilbert | Arizona | 85234 | United States | Details | |
Roswell Park Comprehensive Cancer Center | Buffalo | New York | 14263 | United States | Details | |
Ohio State University Comprehensive Cancer Center | Columbus | Ohio | 43219 | United States | Details | |
Abramson Cancer Center of the University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | United States | Details | |
Sarah Cannon Research Institute at Tennessee Oncology | Nashville | Tennessee | 37203 | United States | Details | |
Princess Margaret Cancer Centre | Toronto | Ontario | M5G 2M9 | Canada | Details | |
Jewish General Hospital | Montréal | Quebec | H3T 1E2 | Canada | Details |